OFA group (group T)

Phase 3

BBeijing Friendship Hospital

OFA group (group T) is one of 5 therapeutic programs targeting Opioid Free Anesthesia. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Opioid Free AnesthesiaRecruiting

Opioid Free AnesthesiaPhase 3

Recruiting

Competition

Competitive Landscape

4 competitors in Opioid Free Anesthesia

#DrugCompanyPhaseTrials

OFA group (group T)

BBeijing Friendship Hospital

Phase 3

1 2

S-Ketamine

PPeking University First Hospital

Preclinical

1 3

Opioid Free Anaesthesia

MMedical University of Lodz

Preclinical

1 4

Opioid-Free Analgesics

BBeijing Friendship Hospital

Preclinical

1 5

Remifentanil Hydrochloride

TThe Catholic University of Korea

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

ApprovedRecruiting

Opioid Free Anesthesia

NCT05577962

Clinical

Trials by Indication[1]

Opioid Free Anesthesia1 trial

The Effect of Opioid-free Anesthesia Protocol on the Early Quality of Recovery After Thyroidectomy (TOFA Trial): Study Protocol for a Prospective, Monocentric, Randomized, Single-blinded Trial

Recruiting·BBeijing Friendship Hospital·Approved·NCT05577962·160 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for OFA group (group T). U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for OFA group (group T). EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Beijing Friendship Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: BBeijing Friendship Hospital

OFA group (group T)

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Opioid Free Anesthesia1 trial

References

Drug Info

Quick Facts

Related News